Alice P. Albright

Director Ejecutivo en Millennium Challenge Corp. .

Health Technology

Government

Perfil

Alice P.
Albright is currently the Chief Executive Officer at Millennium Challenge Corp.
Prior to this, she was the Director-Emeritus at International AIDS Vaccine Initiative, Inc.

Cargos activos de Alice P. Albright

Empresas	Cargo	Inicio
Millennium Challenge Corp.	Director Ejecutivo	01/02/2022

Todos los cargos activos de Alice P. Albright

Antiguos cargos conocidos de Alice P. Albright.

Empresas	Cargo	Fin
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Alice P. Albright.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Alice P. Albright.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.	Health Technology
Millennium Challenge Corp.	Government